Sunder Biomedical Tech. , Ltd. Profit Margin

The latest profit margin for 4115.TWO is -0.29% as of June 2026. That compares with -1.6% in the prior-year period — up 81.7% year over year. That is below the sector sector average of 13.16%. Investors often review this figure alongside Sunder Biomedical Tech. , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 4115.TWO's profit margin moved from -1.6% to -0.29% — a 81.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sunder Biomedical Tech. , Ltd.'s valuation or profitability profile.

Against its sector companies, 4115.TWO currently prints -0.29% for profit margin, while the sector average sits near 13.16%. That is roughly 102.2% below the sector mean. Large gaps often invite a closer look at Sunder Biomedical Tech. , Ltd.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Sunder Biomedical Tech. , Ltd. converts resources into returns. At -0.29%, 4115.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.6% in the prior-year period — up 81.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 4115.TWO's profit margin (-0.29%), review year-over-year change from -1.6%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.